This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Feb. 26, 2013 /PRNewswire/ -- Cell Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its fourth quarter and full year 2012 financial results on
Thursday, February 28, 2013, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a webcast conference call to discuss the results and provide a general corporate update, at
4:30 p.m. ET (
1:30 p.m. PT). Access to the event can be obtained as follows:
Thursday, February 28th1:30 p.m. PT/
4:30 p.m. ET/
10:30 p.m. CET1-877-941-6009 (domestic) +1 480-629-9819 (international)
To access the live audio webcast or the subsequent archived recording, visit CTI's website,
www.celltherapeutics.com. Webcast and telephone replays of the conference call will be available at approximately two hours after completion of the call. Callers can access the replay by dialing 1-800-406-7325 (domestic) or +1 303-590-3030 (international). The access code for the replay is 4603217#. The webcast will be recorded and available for replay on CTI's website until
April 30, 2013.
About Cell Therapeutics, Inc.
Cell Therapeutics (NASDAQ and MTA: CTIC) is a biopharmaceutical company committed to the development and commercialization of an integrated portfolio of oncology products aimed at making cancer more treatable. CTI is headquartered in
Seattle, WA. For additional information and to sign up for email alerts and get RSS feeds, please visit the company's website at
Contacts:Monique Greer +1 206.272.4343
email@example.comEd Bell+1 206.282.7100
SOURCE Cell Therapeutics, Inc.